{"id":"W2898792243","doi":"10.3851/imp3278","title":"Daclatasvir and Sofosbuvir with Ribavirin for 24 Weeks in Chronic Hepatitis C Genotype-3-Infected Patients with Cirrhosis: A Phase III Study (ALLY-3C)","year":2018,"lang":"en","type":"article","venue":"Antiviral Therapy","topic":"Hepatitis C virus research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"St. Paul's Hospital; Toronto General Hospital; University of Toronto; Regina General Hospital; University of Alberta; University of Saskatchewan; Research Canada","funders":"Daiichi Sankyo Europe; Gilead Sciences; Pfizer; Daiichi-Sankyo; Bristol-Myers Squibb","keywords":"Sofosbuvir; Daclatasvir; Ribavirin; Medicine; Internal medicine; Cirrhosis; Hepatitis C; Gastroenterology; Clinical endpoint; Adverse effect; Hepatitis C virus; Virology; Clinical trial; Virus","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003565558,0.0003588677,0.0006099356,0.000302106,0.0001650696,0.00006927206,0.0001649279,0.0001169239,0.00008459879],"category_scores_gemma":[0.00004015979,0.0002555424,0.00005002374,0.0005799615,0.0003479637,0.0003199213,0.00005801408,0.0003242278,0.0000243497],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002094936,"about_ca_system_score_gemma":0.0003570035,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002105874,"about_ca_topic_score_gemma":0.008659254,"domain_scores_codex":[0.9975682,0.0001648145,0.0003783492,0.0006617919,0.0005492797,0.0006775821],"domain_scores_gemma":[0.9987738,0.00009914223,0.0001180255,0.0005229152,0.0003298859,0.0001562558],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00800852,0.00225962,0.8679591,0.00003886129,0.0003197906,0.000066037,0.001197567,2.51262e-7,0.003397877,0.00001587165,0.0002868097,0.1164497],"study_design_scores_gemma":[0.07742739,0.05281839,0.8565979,0.0002379788,0.00007370152,0.000003894552,0.0000712695,0.0004551086,0.004256322,0.00002687353,0.007577921,0.0004532715],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9941872,0.0002861626,0.0003063352,0.0001174708,0.00005732294,0.004489655,0.00008183713,0.0001213472,0.0003526237],"genre_scores_gemma":[0.9979077,0.0005292129,0.0003595455,0.0002142302,0.0001981423,0.0004007461,0.0001146678,0.0001240134,0.0001517332],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1159965,"threshold_uncertainty_score":0.9999897,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02779111316162918,"score_gpt":0.3371077543208006,"score_spread":0.3093166411591714,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}